DOWDUPONT INC. (Exact name of registrant as specified in its charter)

Transcription

1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 2, 2017 DOWDUPONT INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) (Commission file number) (IRS Employer Identification No.) c/o The Dow Chemical Company c/o E. I. du Pont de Nemours and Company 2030 Dow Center, Midland, MI Centre Road, Wilmington, DE (989) (302) Not applicable (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: Written communications pursuant to Rule 425 under the Securities Act (17 CFR ) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR e-4(c)) Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 ( of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 ( b-2 of this chapter). Emerging growth company If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

2 Section 2 - Financial Information Item 2.02 Results of Operations and Financial Condition. On November 2, 2017, DowDuPont Inc. issued a press release and related presentation, attached as Exhibits 99.1 and 99.2, respectively, and incorporated herein by reference, announcing results for the third quarter of The information contained in this report, including Exhibit 99.1 and Exhibit 99.2 attached hereto, is being furnished and shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of Section 18. Furthermore, the information contained in this report shall not be deemed to be incorporated by reference into any registration statement or other document filed pursuant to the Securities Act of 1933, as amended. Section 9 - Financial Statements and Exhibits Item 9.01 Financial Statements and Exhibits. (d) Exhibits Press release issued by DowDuPont Inc. on November 2, 2017, announcing results for the third quarter of DowDuPont Inc. 3Q17 Earnings Conference Call Presentation dated November 2, 2017.

3 SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: November 2, 2017 DOWDUPONT INC. Registrant By: /s/ JEANMARIE F. DESMOND By: /s/ RONALD C. EDMONDS Name: Jeanmarie F. Desmond Name: Ronald C. Edmonds Title: Co-Controller Title: Co-Controller City: Wilmington City: Midland State: Delaware State: Michigan

4 EXHIBIT INDEX Exhibit No. Description 99.1 Press release issued by DowDuPont Inc. on November 2, 2017, announcing results for the third quarter of DowDuPont Inc. 3Q17 Earnings Conference Call Presentation dated November 2, 2017.

5 Exhibit 99.1 DowDuPont Reports Third Quarter 2017 Results GAAP Diluted EPS of $0.32; Pro Forma Adjusted EPS Increases 10% to $0.55 GAAP Net Income of $514MM; Pro Forma Operating EBITDA Grows 7% to $3.2B GAAP Net Sales of $15.4B; Pro Forma Net Sales Increase 8% to $18.3B, with Gains in Most Segments and Geographies GAAP Volume Up 5%, Local Price Up 4%; Pro Forma Volume Up 4%, Local Price Up 3% Third Quarter 2017 Highlights DowDuPont reported GAAP diluted earnings 1 per share of $0.32. Pro forma adjusted earnings 2 per share of $0.55 increased 10 percent compared to the year-ago period. Pro forma adjusted earnings per share excludes significant items in the quarter, which totaled charges of $0.37 per share, as well as $0.08 per share for DuPont amortization of intangible assets. GAAP net sales increased 23 percent. Pro forma net sales increased to $18.3 billion, up 8 percent versus the year-ago period, led by gains in the Materials Science segments Industrial Intermediates & Infrastructure (16 percent), Packaging & Specialty Plastics and Performance Materials & Coatings (8 percent each), and the Specialty Products segments Transportation & Advanced Polymers (9 percent) and Safety & Construction (6 percent). Sales rose double-digits in Europe, Middle East and Africa (EMEA) (16 percent) and in Asia Pacific (10 percent). Sales in North America grew 4 percent, while sales in Latin America declined driven by weakness in Agriculture due to expected lower corn area and a delayed start to the summer season in Brazil. Pro forma volume grew 4 percent, reflecting consumer-led demand in packaging, electronics, transportation, oil and gas, building and construction, and consumer care end-markets. Volume grew in almost all operating segments, led by Electronics & Imaging (13 percent), as well as Packaging & Specialty Plastics and Safety & Construction (6 percent each). Regional volume gains were led by Asia Pacific (10 percent) and EMEA (5 percent). Pro forma local price rose 3 percent, led by Industrial Intermediates & Infrastructure (12 percent), Performance Materials & Coatings (6 percent), and Transportation & Advanced Polymers (3 percent). Pro forma local price increased in all geographies except Latin America. Pro forma operating EBITDA 3 increased 7 percent to $3.2 billion, driven by volume and price gains; higher equity earnings; and lower pension/opeb costs 4 due to purchase accounting. These gains more than offset higher feedstock costs, weak conditions in agriculture markets, the unfavorable impact of hurricanes, and startup costs related to new assets on the U.S. Gulf Coast. In millions, except per share amounts Three Months Ended September 30 Nine Months Ended September % Change % Change GAAP Net Sales $15,354 $12,483 23% $42,418 $35,138 21% GAAP Net Income 5 $514 $719 (29%) $2,723 $4,011 (32)% GAAP Diluted EPS $0.32 $0.63 (49%) $2.01 $3.48 (42%) Pro Forma Net Sales $18,285 $16,991 8% $59,469 $53,160 12% Pro Forma Net Income 5 $232 $494 (53%) $3,959 $5,428 (27%) Pro Forma Operating EBITDA $3,221 $3,022 7% $12,228 $10,929 12% Pro Forma Adjusted EPS $0.55 $ % $2.56 $ % (1) GAAP diluted earnings per share reflects three months of Dow earnings and one month of DuPont earnings. This compares with GAAP earnings per share of $0.63 year-over-year. (2) Pro forma information before adjustments for significant items and DuPont intangible asset amortization was determined in accordance with Article 11 of Regulation S-X and is discussed to increase comparability to the prior year pre-merger operating results by adjusting for the merger of Dow and DuPont. Pro forma information is reconciled to the most comparable GAAP results in the attached tables. Pro forma adjusted earnings per share is defined as Pro Forma earnings per common share from continuing operations - diluted excluding the after-tax impact of pro forma significant items and the after-tax impact of pro forma amortization expense associated with DuPont s intangible assets. See the financial information at the end of the release for a description of the significant items, as well as a reconciliation of Pro forma earnings per common share from continuing operations - diluted to Pro forma adjusted earnings per common share from continuing operations - diluted. (3) Pro forma operating EBITDA is defined as earnings (i.e., Pro Forma income from continuing operations before income taxes ) before interest, depreciation, amortization and foreign exchange gains (losses) excluding the impact of significant items. A reconciliation of "Pro Forma income from continuing operations, net of tax to Pro Forma Operating EBITDA is provided in the financial schedules at the end of the release. (4) Pension/OPEB (other post employment benefit plans) costs include all components of net periodic benefit cost from continuing operations. (5) Net income available for DowDuPont Inc. common stockholders.

6 Strategic Updates On September 12, DowDuPont announced certain targeted portfolio adjustments to the Materials Science and Specialty Products divisions to align with end-markets and enhance the competitive advantages of the intended companies. The Company started up its new ethylene and ELITE enhanced polyethylene facilities, both in Freeport, Texas. The Sadara joint venture achieved full commercial operations of all 26 production facilities at its world-scale complex. DowDuPont continued to satisfy conditional regulatory clearances required of the merger transaction. On November 1, DuPont closed the divestiture of its cereal broadleaf herbicides and chewing insecticides portfolios, as well as certain parts of its crop protection R&D pipeline and organization to FMC, and closed its acquisition of FMC's Health and Nutrition business. On September 1, Dow completed the sale of its global PRIMACOR ethylene acrylic acid copolymers and ionomers business. Dow expects to close its divestiture of a select portion of Dow AgroSciences' corn seed business in Brazil in the fourth quarter of The Company continues to make progress integrating the three divisions and has initiated work to prepare for the intended separation into three independent companies in Agriculture, Materials Science and Specialty Products. DowDuPont reiterated its commitment to the $3 billion cost synergy target and updated expectations by division: Agriculture - $1.0 billion; Materials Science - $1.2 billion; Specialty Products - $0.8 billion. The Company began advancing its playbook to deliver $1 billion in growth synergies. For example, Agriculture will leverage its enhanced multi-brand, multi-channel approach designed to provide customers more value through broader choices and whole-farm solutions. Packaging & Specialty Plastics has begun the process of integrating DuPont s resins and ethylene copolymers portfolio to deliver high performance packaging solutions. Electronics & Imaging has identified opportunities to leverage its deeper channel access and broader suite of materials (OLED films, laminates, semiconductor materials) with its customers. DowDuPont announced today actions taken to generate cost savings of $3 billion. These actions are designed to integrate the organization post-merger and create strong foundations for the three intended companies. The majority of this work will come from procurement synergies, global workforce reductions, buildings and facilities consolidations and select asset shutdowns, among other activities. In connection with the actions approved to date, DowDuPont recognized pre-tax charges of $180 million in the third quarter. The Company expects to recognize total pre-tax charges of approximately $2 billion, with approximately $1 billion expected in the fourth quarter of The program is expected to achieve a 70 percent run rate at the end of 12 months and 100 percent run rate within 24 months. CEO Quote We delivered top- and bottom-line growth in the third quarter - a solid start for our newly-formed company. Our operating earnings increase was the result of broad-based demand growth in most of our core end-markets and disciplined margin management, which more than offset several headwinds, from multiple hurricanes to higher feedstock costs and a delayed start to the summer agriculture season in Brazil, said Ed Breen, chief executive officer of DowDuPont. Moreover, we delivered these results while advancing several value-creating initiatives, including: closing the merger, completing our comprehensive portfolio review, and defining the new synergy targets for each division. Going forward, you should expect us to remain focused on executing on our $3 billion cost synergy commitment and advancing preparations to create three focused growth companies in Agriculture, Materials Science, and Specialty Products.

7 Third Quarter Segment Information Agriculture The segment reported pro forma net sales of $1.9 billion, down from $2.0 billion in the year-ago period. Pro forma volume and pro forma local price declines of 5 percent and 4 percent, respectively, more than offset portfolio and currency benefits. Volume and pricing headwinds were driven by weakness in Latin America as sales channels continue to hold high inventory levels of crop protection products. Additionally, an expected reduction in corn area in Brazil, as well as a delayed start to its summer season, impacted sales in the region. These headwinds were partly offset by continued penetration of new products, including Arylex TM herbicide, Vessarya fungicide, Leptra corn hybrids and Isoclast TM insecticide. Portfolio gains in the quarter reflect the Dow AgroSciences corn seed remedy in Brazil, which is expected to close in the fourth quarter. Per Securities & Exchange Commission guidelines, the results of the Brazil corn remedy have been removed from pro forma results prior to the merger close date but will remain in reported results from the merger close date until the transaction has closed. Pro forma operating EBITDA for the segment was a loss of $239 million, versus a loss of $172 million in the year-ago period. Lower product costs, favorable currency, portfolio changes and lower pension/opeb costs were more than offset by reduced volume and price, particularly due to weakness in Brazil. Materials Science Performance Materials & Coatings Performance Materials & Coatings reported pro forma net sales of $2.2 billion, up from $2.0 billion in the year-ago period. Pro forma net sales growth of 8 percent was primarily driven by gains in both businesses as well as double-digit growth in EMEA. Pro forma local price increased 6 percent, with gains in all geographies and both businesses. Pro forma volume grew 1 percent. Consumer Solutions delivered sales growth in all businesses, led by volume gains in most geographies, increased local pricing and disciplined price/volume management in upstream silicone intermediate products. Coatings & Performance Monomers achieved higher sales, as local price increases in all geographies more than offset a modest decline in volume due to hurricane-related lost sales and the business s actions to preferentially shed lower margin business. Pro forma operating EBITDA increased to $487 million, up from $345 million in the year-ago period. The increase primarily reflected the continued realization of cost synergies related to the integration of the silicones business, increased pricing and consumer demand. Pro forma equity earnings for the segment totaled $39 million, compared with $31 million in the year-ago period.

8 Industrial Intermediates & Infrastructure Industrial Intermediates & Infrastructure reported pro forma net sales of $3.2 billion, up from $2.8 billion in the year-ago period. The segment achieved pro forma net sales growth of 16 percent, with gains in all geographies. Pro forma local price rose 12 percent. Pro forma volume grew 3 percent. Polyurethanes & Chlor-Alkali and Vinyl (CAV) grew sales on double-digit gains in all geographies. Polyurethanes reported strong demand and price increases in downstream, higher-margin systems applications and higher merchant sales of methylene diphenyl diisocyanate (MDI) where industry supply/demand fundamentals remained tight, in part due to hurricane-related supply disruptions in the United States. CAV achieved double-digit sales gains in vinyl chloride monomer and caustic soda, resulting from tighter supply/demand fundamentals, especially in EMEA. Industrial Solutions also delivered sales gains, led by glycol ethers, ethylene glycol and oxo alcohols in consumer-driven market segments of electronics processing and food and pharmaceutical applications. These gains more than offset lower sales of heat transfer fluids in project-driven concentrated solar power applications and hurricane-related supply constraints. Construction Chemicals achieved sales growth driven by demand for methyl cellulosics in EMEA and acrylics-based products in North America. Energy Solutions reported lower sales from reduced project activity in energy market sectors, in part due to hurricane-related disruptions in the United States. The segment achieved pro forma operating EBITDA of $676 million, up from $401 million in the year-ago period, as pricing momentum, higher equity earnings and broad-based demand growth more than offset the impact of higher raw material costs, as well as hurricane-related repair costs and lost production in North America. Pro forma equity earnings for the segment totaled $41 million, compared with a pro forma equity loss of $7 million in the year-ago period. The improvement was driven by the Kuwait joint ventures as a result of higher monoethylene glycol (MEG) pricing. Packaging & Specialty Plastics The Packaging & Specialty Plastics segment reported pro forma net sales of $5.5 billion, up from $5.1 billion in the year-ago period. The segment achieved pro forma net sales growth of 8 percent, primarily driven by pro forma volume growth of 6 percent, with gains in most geographic areas. Pro forma local price rose 1 percent, led by higher cracker co-product values. The Packaging and Specialty Plastics business grew volume on continued consumer-led demand across key end-markets, driven by higher sales in Asia Pacific and EMEA, which were primarily enabled by a ramp-up in Sadara volume. Notable demand highlights included double-digit volume growth in health and hygiene end-markets in the Americas; strong demand in food and specialty packaging solutions, particularly in Asia Pacific; and greater use of elastomers in packaging and footwear applications. Polyethylene and ethylene copolymers sales volume in North America and Latin America declined year-overyear, impacted by the hurricane-related production disruptions in the United States. Sales into wire and cable applications were impacted globally as a result of hurricane-related supply limitations at the business s assets in Texas. Pro forma operating EBITDA for the segment was $1.1 billion, down from $1.4 billion in the year-ago period. Volume growth, local price gains and higher equity earnings were more than offset by increased feedstock costs, hurricane-related repair costs and lost production in the United States, and commissioning and startup costs for the U.S. Gulf Coast growth projects.

9 Pro forma equity earnings for the segment were $66 million, up from $44 million in the year-ago period, primarily driven by improved Sadara contributions on higher sales of polyethylene. Specialty Products Electronics & Imaging Electronics & Imaging delivered pro forma net sales of $1.2 billion, up from $1.1 billion in the year-ago period. Pro forma net sales growth of 5 percent was led by pro forma volume gains of 13 percent, which more than offset pro forma local price decline of 2 percent and a 6 percent negative pro forma impact from portfolio. Price declines were driven by pressure in photovoltaics and advanced printing applications. The segment achieved broad-based volume growth across key end-markets, led by double-digit gains in semiconductor, consumer electronics, industrial, photovoltaics and display end-markets across almost all geographies, primarily in Asia Pacific. Continued demand for mobile phones and other consumer electronics, as well as automotive applications drove sales gains. Increased semiconductor content in end-use applications drove strong demand in both memory and logic market segments. Growth in photovoltaics led by demand for Tedlar film was partially offset by declines in Solamet paste. The portfolio impact from the sales of Display Films and the Authentications business also negatively impacted results. Pro forma operating EBITDA for the segment was $382 million, up from $341 million in the year-ago period as broad-based volume growth, mix enrichment and lower pension/opeb costs more than offset lower local price and a negative impact from portfolio. Nutrition & Biosciences Nutrition & Biosciences reported pro forma net sales of $1.5 billion, flat with the year-ago period. Pro forma net sales were even as a 1 percent benefit from currency was offset by a 1 percent negative impact from portfolio. Sales growth in Industrial Biosciences was offset by declines in the Nutrition & Health business. Industrial Biosciences gains were led by double-digit growth in demand for microbial control solutions in energy markets in North America, continued growth in biomaterials on local pricing gains and strength in apparel markets, as well as increased demand for bioactives in animal nutrition markets. In Nutrition & Health, continued growth in probiotics was more than offset by declines in protein solutions and systems and texturants due to weakness in global packaged food markets and specific actions taken to exit low-margin market segments. The negative portfolio impact was driven by the sale of the Diagnostic business, which also impacted Nutrition & Health results. Pro forma operating EBITDA for the segment was $315 million, down from $321 million in the year-ago period as growth in Industrial Biosciences and lower pension/opeb costs were more than offset by declines in Nutrition & Health. Transportation & Advanced Polymers Transportation & Advanced Polymers achieved pro forma net sales of $1.3 billion, up from $1.2 billion in the year-ago period. Pro forma net sales grew 9 percent, led by pro forma volume growth of 5 percent as well as pro forma local price gains of 3 percent, with gains in most geographies. Growth was led by strong demand from the automotive market, particularly in Asia Pacific and EMEA, and demand from electronics and industrial markets. Volume growth was driven by strength in the automotive market as demand for engineering polymers, structural adhesives and MolyKote lubricants outpaced global autobuild rates. Volume gains were also achieved by Kalrez and Vespel high-performance parts as strength in the aerospace and electronics markets remained robust. Pro forma operating EBITDA increased to $325 million, up from $303 million in the year-ago period. Volume and pricing gains and lower pension/opeb costs more than offset higher raw material costs. Safety & Construction The Safety & Construction segment reported pro forma net sales of $1.3 billion, up from $1.2 billion in the year-ago period. The segment delivered pro forma net sales growth of 6 percent, driven by a pro forma volume increase of 6 percent, with gains in all geographies. Regionally, volume gains came from Nomex thermal apparel in North America, Kevlar high-strength materials in Asia Pacific and Latin America, and Tyvek protective materials for graphics and house wrap in EMEA and Asia Pacific.

10 Stronger demand from industrial markets, particularly oil and gas, contributed to double-digit gains in Nomex thermal-resistant garments and mid-single-digit gains in Kevlar high-strength materials, including umbilicals for deep sea drilling, as well as higher sales of intermediates. Mid-single-digit gains in Tyvek protective materials reflected growth in graphics and house wraps. Double-digit volume increases in water filtration reflected gains in reverse osmosis membranes, due to strong demand from industrial markets, as well as recent capacity increases. Building solutions sales rose modestly due to local price. Pro forma operating EBITDA rose to $351 million, compared with $282 million in the year-ago period. Volume gains, lower pension/opeb costs and improved plant performance more than offset the impact of higher raw material costs. The segment also benefited from one-time gains of $30 million, primarily associated with the benefit related to an acquisition. Outlook Consumer-led demand continues to drive global economic activity, which remains robust across most major economies, including Europe, China and the United States. Our demand outlook is positive for the majority of our key end-markets, said Andrew Liveris, executive chairman of DowDuPont. We still see some market headwinds, the most notable for us being in agriculture where we continue to closely monitor the situation in Brazil due to the slow start to the summer season. But we remain confident that we will have a solid year across our newly combined Ag division. Looking forward, DowDuPont has all the levers it needs to execute our near-term priorities: delivering earnings and cash flow growth; executing our cost synergy actions and realizing the savings; advancing stand-up activities for the intended growth companies; and unlocking the shareholder value creation envisaged through this historic transaction. Conference Call The Company will host a live webcast of its third quarter earnings conference call with investors to discuss its results, business outlook and other matters today at 8:00 a.m. ET. The slide presentation that accompanies the conference call will be posted on the DowDuPont Investor Relations events and presentations page. A replay of the webcast will also be available on the investor events and presentations page of

11 About DowDuPont DowDuPont (NYSE: DWDP) is a holding company comprised of The Dow Chemical Company and DuPont with the intent to form strong, independent, publicly traded companies in agriculture, materials science and specialty products sectors that will lead their respective industries through productive, science-based innovation to meet the needs of customers and help solve global challenges. For more information, please visit us at Contact Information: Investors: Greg Friedman greg.friedman@dupont.com Neal Sheorey nrsheorey@dow.com Media Rachelle Schikorra ryschikorra@dow.com Dan Turner daniel.a.turner@dupont.com Cautionary Statement About Forward-Looking Statements This communication contains forward-looking statements within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In this context, forward-looking statements often address expected future business and financial performance and financial condition, and often contain words such as expect, anticipate, intend, plan, believe, seek, see, will, would, target, similar expressions, and variations or negatives of these words. On December 11, 2015, The Dow Chemical Company ( Dow ) and E. I. du Pont de Nemours and Company ( DuPont ) announced entry into an Agreement and Plan of Merger, as amended on March 31, 2017, (the Merger Agreement ) under which the companies would combine in an all-stock merger of equals transaction (the Merger Transaction ). Effective August 31, 2017, the Merger Transaction was completed and each of Dow and DuPont became subsidiaries of DowDuPont Inc. ( DowDuPont ). For more information, please see each of DowDuPont s, Dow s and DuPont s latest annual, quarterly and current reports on Forms 10-K, 10-Q and 8-K, as the case may be, and the joint proxy statement/prospectus included in the registration statement on Form S-4 filed by DowDuPont with the SEC on March 1, 2016 (File No ), as last amended on June 7, 2016, and declared effective by the SEC on June 9, 2016 (the Registration Statement ) in connection with the Merger Transaction. Forward-looking statements by their nature address matters that are, to different degrees, uncertain, including the intended separation of DowDuPont s agriculture, materials science and specialty products businesses in one or more tax efficient transactions on anticipated terms (the Intended Business Separations ). Forward-looking statements are not guarantees of future performance and are based on certain assumptions and expectations of future events which may not be realized. Forward-looking statements also involve risks and uncertainties, many of which are beyond the company s control. Some of the important factors that could cause DowDuPont s, Dow s or DuPont s actual results to differ materially from those projected in any such forward-looking statements include, but are not limited to: (i) successful integration of the respective agriculture, materials science and specialty products businesses of Dow and DuPont, including anticipated tax treatment, unforeseen liabilities, future capital expenditures, revenues, expenses, earnings, productivity actions, economic performance, indebtedness, financial condition, losses, future prospects, business and management strategies for the management, expansion and growth of the combined operations; (ii) impact of the divestitures required as a condition to consummation of the Merger Transaction as well as other conditional commitments; (iii) achievement of the anticipated synergies by DowDuPont s agriculture, materials science and specialty products businesses; (iv) risks associated with the Intended Business Separations, including those that may result from the comprehensive portfolio review undertaken by the DowDuPont board, changes and timing, including a number of conditions which could delay, prevent or otherwise adversely affect the proposed transactions, including possible issues or delays in obtaining required regulatory approvals or clearances related to the Intended Business Separations, disruptions in the financial markets or other potential barriers; (v) the risk that disruptions from the Intended Business Separations will harm DowDuPont s business (either directly or as conducted by and through Dow or DuPont), including current plans and operations; (vi) the ability to retain and hire key personnel; (vii) potential adverse reactions or changes to business relationships resulting from the completion of the merger or the Intended Business Separations; (viii) uncertainty as to the long-term value of DowDuPont common stock; (ix) continued availability of capital and financing and rating agency actions; (x) legislative, regulatory and economic developments; (xi) potential business uncertainty, including changes to existing business relationships, during the pendency of the Intended Business Separations that could affect the company s financial performance and (xii) unpredictability and severity of catastrophic events, including, but not limited to, acts of terrorism or outbreak of war or hostilities, as well as management s response to any of the aforementioned factors. These risks, as well as other risks associated with the merger and the Intended Business Separations, are more fully discussed in (1) the Registration Statement and (2) the current, quarterly and annual reports filed with the SEC by DowDuPont and to the extent incorporated by reference into the Registration Statement, by Dow and DuPont. While the list of factors presented here is, and the list of factors presented in the Registration Statement are, considered representative, no such list should be considered to be a complete statement of all potential risks and uncertainties. Unlisted factors may present significant additional obstacles to the realization of forward-looking statements. Consequences of material differences in results as compared with those anticipated in the forward-looking statements could include, among other things, business disruption, operational problems, financial loss, legal liability to third parties and similar risks, any of which could have a material adverse effect on DowDuPont s, Dow s or DuPont s consolidated financial condition, results of operations, credit rating or liquidity. None of DowDuPont, Dow or DuPont assumes any obligation to publicly provide revisions or updates to any forward-looking statements whether as a result of new information, future developments or otherwise, should circumstances change, except as otherwise required by securities and other applicable laws. The Dow Diamond, DuPont Oval logo, DuPont and all products, unless otherwise noted, denoted with, or are trademarks or registered trademarks of The Dow Chemical Company, E. I. du Pont de Nemours and Company or their affiliates.

12 Merger of Equals Effective August 31, 2017, pursuant to the merger of equals transaction contemplated by the Agreement and Plan of Merger, dated as of December 11, 2015, as amended on March 31, 2017 (the "Merger Agreement"), The Dow Chemical Company ("Dow") and E. I. du Pont de Nemours & Company ("DuPont") each merged with subsidiaries of DowDuPont, Inc. ("DowDuPont" or the "Company") and, as a result, Dow and DuPont became subsidiaries of DowDuPont Inc. (the "Merger"). Dow was determined to be the accounting acquirer in the Merger and, as a result, the historical financial statements of Dow, prepared under U.S. generally accepted accounting principles ("U.S. GAAP"), for the periods prior to the Merger are considered to be the historical financial statements of DowDuPont. Unaudited Pro Forma Financial Information In order to provide the most meaningful comparison of results of operations and results by segment, supplemental unaudited pro forma financial information has been included in the following financial schedules. The unaudited pro forma financial information is based on the historical consolidated financial statements and accompanying notes of both Dow and DuPont and has been prepared to illustrate the effects of the Merger, assuming the Merger had been consummated on January 1, For all periods presented, adjustments have been made for (1) the preliminary purchase accounting impact, (2) accounting policy alignment, (3) eliminate the effect of events that are directly attributable to the Merger Agreement (e.g., one-time transaction costs), (4) eliminate the impact of transactions between Dow and DuPont, and (5) eliminate the effect of consummated or probable and identifiable divestitures agreed to with certain regulatory agencies as a condition of approval for the Merger. The unaudited pro forma financial information was based on and should be read in conjunction with the separate historical financial statements and accompanying notes contained in each of the Dow and DuPont Quarterly Reports on Form 10-Q and Annual Reports on Form 10-K for the applicable periods. The pro forma financial statements were prepared in accordance with Article 11 of Regulation S-X. The unaudited pro forma financial information has been presented for informational purposes only and is not necessarily indicative of what DowDuPont's results of operations actually would have been had the Merger been completed as of January 1, 2016, nor is it indicative of the future operating results of DowDuPont. The unaudited pro forma financial information does not reflect any cost or growth synergies that DowDuPont may achieve as a result of the Merger, future costs to combine the operations of Dow and DuPont or the costs necessary to achieve any cost or growth synergies. Non-GAAP Financial Measures This earnings release includes information that does not conform to U.S. GAAP and are considered non-gaap measures. These measures include the Company's pro forma consolidated results and pro forma earnings per share on an adjusted basis, which excludes the after-tax impact of pro forma significant items and the after-tax impact of pro forma amortization expense associated with DuPont's intangible assets. Management uses these measures internally for planning, forecasting and evaluating the performance of the Company's segments, including allocating resources. DowDuPont's management believes that these non-gaap measures best reflect the ongoing performance of the Company during the periods presented and provide more relevant and meaningful information to investors as they provide insight with respect to ongoing operating results of the Company and a more useful comparison of year-over-year results. These non-gaap measures supplement the Company's U.S. GAAP disclosures and should not be viewed as an alternative to U.S. GAAP measures of performance. Furthermore, such non-gaap measures may not be consistent with similar measures provided or used by other companies.

13 DowDuPont Inc. Consolidated Statements of Income Three Months Ended Nine Months Ended In millions, except per share amounts (Unaudited) Sep 30, 2017 Sep 30, 2016 Sep 30, 2017 Sep 30, 2016 Net sales $ 15,354 $ 12,483 $ 42,418 $ 35,138 Cost of sales 12,170 9,840 33,130 27,066 Research and development expenses ,343 1,159 Selling, general and administrative expenses ,468 2,166 Amortization of intangibles Restructuring and asset related charges - net Integration and separation costs Equity in earnings of nonconsolidated affiliates Sundry income (expense) - net ,369 Interest expense and amortization of debt discount Income from continuing operations before income taxes 1,125 1,089 4,067 4,611 Provision for income taxes on continuing operations , Income from continuing operations, net of tax ,828 4,320 Loss from discontinued operations, net of tax (20) (20) Net income ,808 4,320 Net income attributable to noncontrolling interests Net income attributable to DowDuPont Inc ,723 4,266 Preferred stock dividends Net income available for DowDuPont Inc. common stockholders $ 514 $ 719 $ 2,723 $ 4,011 Per common share data: Earnings per common share from continuing operations - basic $ 0.33 $ 0.64 $ 2.05 $ 3.60 Loss per common share from discontinued operations - basic (0.01) (0.01) Earnings per common share - basic $ 0.32 $ 0.64 $ 2.04 $ 3.60 Earnings per common share from continuing operations - diluted $ 0.33 $ 0.63 $ 2.02 $ 3.48 Loss per common share from discontinued operations - diluted (0.01) (0.01) Earnings per common share - diluted $ 0.32 $ 0.63 $ 2.01 $ 3.48 Dividends declared per share of common stock $ 0.46 $ 0.46 $ 1.38 $ 1.38 Weighted-average common shares outstanding - basic 1, , , ,108.8 Weighted-average common shares outstanding - diluted 1, , , ,220.4 Note: The consolidated statements of income for the three - and nine -month periods ended September 30, 2017 and September 30, 2016, reflect the results of Dow for all periods presented and the results of DuPont for the period beginning on and after September 1, 2017.

14 DowDuPont Inc. Consolidated Balance Sheets In millions, except per share amounts (Unaudited) Sep 30, 2017 Dec 31, 2016 Current Assets Assets Cash and cash equivalents (variable interest entities restricted : $115; 2016: $75) $ 13,148 $ 6,607 Marketable securities 1,826 Accounts and notes receivable: Trade (net of allowance for doubtful receivables : $171; 2016: $110) 11,250 4,666 Other 7,006 4,312 Inventories 17,284 7,363 Other current assets 1, Assets held for sale 3,171 Total current assets 54,830 23,659 Investments Investment in nonconsolidated affiliates 5,650 3,747 Other investments (investments carried at fair value : $1,408; 2016: $1,959) 2,450 2,969 Noncurrent receivables Total investments 8,843 7,424 Property Property 72,227 57,438 Less accumulated depreciation 36,008 33,952 Net property (variable interest entities restricted : $925; 2016: $961) 36,219 23,486 Other Assets Goodwill 60,791 15,272 Other intangible assets (net of accumulated amortization : $4,990; 2016: $4,295) 33,460 6,026 Deferred income tax assets 1,810 3,079 Deferred charges and other assets 2, Total other assets 98,797 24,942 Total Assets $ 198,689 $ 79,511 Current Liabilities Liabilities and Equity Notes payable $ 5,176 $ 272 Long-term debt due within one year 1, Accounts payable: Trade 7,648 4,519 Other 3,862 2,097 Income taxes payable Accrued and other current liabilities 7,849 4,481 Liabilities held for sale 108 Total current liabilities 27,278 12,604 Long-Term Debt (variable interest entities nonrecourse : $310; 2016: $330) 29,819 20,456 Other Noncurrent Liabilities Deferred income tax liabilities 9, Pension and other postretirement benefits - noncurrent 18,413 11,375 Asbestos-related liabilities - noncurrent 1,266 1,364 Other noncurrent obligations 8,092 5,560 Total other noncurrent liabilities 36,896 19,222 Stockholders' Equity Common stock (2017: authorized 5,000,000,000 shares of $0.01 par value each, issued 2,339,396,931 shares; 2016: authorized 1,500,000,000 shares of $2.50 par value each, issued 1,242,794,836) 23 3,107 Additional paid-in capital 81,116 4,262 Retained earnings 31,366 30,338 Accumulated other comprehensive loss (9,205) (9,822) Unearned ESOP shares (192) (239) Treasury stock at cost (2017: zero shares; 2016: 31,661,501 shares) (1,659) DowDuPont's stockholders' equity 103,108 25,987 Noncontrolling interests 1,588 1,242 Total equity 104,696 27,229 Total Liabilities and Equity $ 198,689 $ 79,511 Note: The consolidated balance sheet at September 30, 2017, reflects the financial position of DowDuPont, Inc. The consolidated balance sheet at December 31, 2016, solely reflects the financial position of Dow.

15 DowDuPont Inc. Pro Forma Consolidated Statements of Income Three Months Ended Nine Months Ended In millions, except per share amounts (Unaudited) Sep 30, 2017 Sep 30, 2016 Sep 30, 2017 Sep 30, 2016 Net sales $ 18,285 $ 16,991 $ 59,469 $ 53,160 Cost of sales 14,246 12,940 43,676 38,308 Research and development expenses ,390 2,299 Selling, general and administrative expenses 1,583 1,586 5,223 5,153 Amortization of intangibles ,286 1,201 Restructuring and asset related charges - net Integration and separation costs Equity in earnings of nonconsolidated affiliates Sundry income (expense) - net 226 (37) 226 1,621 Interest expense and amortization of debt discount Income from continuing operations before income taxes ,184 6,369 Provision for income taxes on continuing operations , Income from continuing operations, net of tax ,071 5,758 Net income attributable to noncontrolling interests Net income attributable to DowDuPont Inc ,959 5,683 Preferred stock dividends Net income available for DowDuPont Inc. common stockholders $ 232 $ 494 $ 3,959 $ 5,428 Per common share data: Earnings per common share from continuing operations - basic $ 0.10 $ 0.22 $ 1.70 $ 2.43 Earnings per common share from continuing operations - diluted $ 0.10 $ 0.22 $ 1.68 $ 2.41 Weighted-average common shares outstanding - basic 2, , , ,222.0 Weighted-average common shares outstanding - diluted 2, , , ,242.4 Note: The pro forma consolidated statements of income for the three - and nine -month periods ended September 30, 2017 and September 30, 2016, reflect the results of operations of Dow and DuPont assuming the Merger had occurred on January 1, Reconciliation of Pro Forma Earnings Per Common Share from Continuing Operations - Diluted to Pro Forma Adjusted Earnings Per Common Share from Continuing Operations - Diluted Dollars per share Three Months Ended Nine Months Ended Sep 30, 2017 Sep 30, 2016 Sep 30, 2017 Sep 30, 2016 Pro forma earnings per common share from continuing operations - diluted $ 0.10 $ 0.22 $ 1.68 $ Earnings per common share impact of pro forma significant items, after-tax 1 (0.37) (0.20) (0.64) Earnings per common share impact of pro forma amortization of DuPont's intangible assets, after-tax (0.08) (0.08) (0.24) (0.25) Pro forma adjusted earnings per common share from continuing operations - diluted (Non-GAAP) 2 $ 0.55 $ 0.50 $ 2.56 $ Refer to the Selected Pro Forma Financial Information and Non-GAAP Measures section for additional information on the impact of pro forma significant items. 2. Pro forma adjusted earnings per share ("Pro Forma Adjusted EPS"), a non-gaap measure, is defined as Pro forma earnings (loss) per common share from continuing operations - diluted, excluding the after-tax impact of pro forma significant items and the after-tax impact of pro forma amortization expense associated with DuPont s intangible assets. The Company s management believes this measure provides useful information to investors by offering an additional way of viewing DowDuPont s results that helps investors identify the underlying earnings of the Company as compared to prior and future periods and its peers. Although amortization of DuPont s intangible assets is excluded from this non-gaap measure, management believes it is important for investors to understand that such intangible assets contribute to revenue generation. Amortization of intangible assets that relate to past acquisitions will recur in future periods until such intangible assets have been fully amortized. Any future acquisitions may result in amortization of additional intangible assets. Pro Forma Adjusted EPS is a financial measure not recognized in accordance with U.S. GAAP and should not be viewed as an alternative to U.S. GAAP financial measures of performance.

16 DowDuPont Inc. Pro Forma Net Sales by Segment and Geographic Region Pro Forma Net Sales by Segment and Geographic Region 1 Three Months Ended Nine Months Ended In millions Sep 30, 2017 Sep 30, 2016 Sep 30, 2017 Sep 30, 2016 Agriculture $ 1,911 $ 1,998 $ 11,555 $ 11,396 Performance Materials & Coatings 2,219 2,046 6,537 4,440 Industrial Intermediates & Infrastructure 3,226 2,770 9,086 8,015 Packaging & Specialty Plastics 5,490 5,070 16,300 14,636 Electronics & Imaging 1,198 1,138 3,583 3,084 Nutrition & Biosciences 1,473 1,469 4,391 4,313 Transportation & Advanced Polymers 1,299 1,187 3,834 3,316 Safety & Construction 1,310 1,238 3,852 3,748 Corporate Total $ 18,285 $ 16,991 $ 59,469 $ 53,160 U.S. & Canada $ 6,339 $ 6,113 $ 23,952 $ 21,862 EMEA 2 5,204 4,496 16,348 14,315 Asia Pacific 4,440 4,033 13,013 11,069 Latin America 2,302 2,349 6,156 5,914 Total $ 18,285 $ 16,991 $ 59,469 $ 53,160 Pro Forma Net Sales Variance by Segment and Geographic Region 1 Percent change from prior year Three Months Ended Sep 30, 2017 Nine Months Ended Sep 30, 2017 Local Price & Product Mix Currency Volume Portfolio / Other 3 Total Local Price & Product Mix Currency Volume Portfolio / Other 4 Total Agriculture (4)% 2% (5)% 3 % (4)% % % 1 % % 1% Performance Materials & Coatings Industrial Intermediates & Infrastructure Packaging & Specialty Plastics Electronics & Imaging (2) 13 (6) 5 (2) Nutrition & Biosciences 1 (1) 3 (1) 2 Transportation & Advanced Polymers Safety & Construction 6 6 (2) 5 3 Total 3 % 1% 4 % % 8 % 4 % % 4 % 4 % 12% U.S. & Canada 1 % % 3 % % 4 % 3 % % 3 % 3 % 9% EMEA (1) Asia Pacific 2 10 (2) Latin America (2) 1 (4) 3 (2) 1 1 (1) 3 4 Total 3 % 1% 4 % % 8 % 4 % % 4 % 4 % 12% 1. Pro forma net sales and net sales variance reflect the results of Dow and DuPont as if the Merger had occurred on January 1, Europe, Middle East and Africa. 3. Pro forma net sales for Agriculture excludes sales related to the expected divestiture of a portion of Dow AgroSciences' corn seed business for the periods July 1, 2016 through September 30, 2016 and July 1, 2017 through August 31, Sales for the month of September 2017 are included in Portfolio/Other. Portfolio/Other for Electronics & Imaging reflects the recent divestitures of the SKC Haas Display Films group of companies (divested on June 30, 2017) and authentication business (divested on January 6, 2017). Portfolio/Other for Nutrition & Biosciences reflects the global food safety diagnostic business (divested on February 28, 2017). 4. Pro forma net sales for Agriculture excludes sales related to the expected divestiture of a portion of Dow AgroSciences' corn seed business for the periods January 1, 2016 through September 30, 2016 and January 1, 2017 through August 31, Sales for the month of September 2017 are included in Portfolio/Other. Portfolio/Other also reflects sales from January 1, 2017 through May 31, 2017 related to the ownership restructure of Dow Corning on June 1, 2016 (impacts Performance Materials & Coatings, Electronics & Imaging and Transportation & Advanced Polymers), the divestitures of SKC Haas Display Films group of companies (divested on June 30, 2017) and the authentication business (divested on January 6, 2017), impacting Electronics & Imaging, and the global food safety diagnostic business (divested on February 28, 2017), impacting Nutrition & Biosciences.

17 DowDuPont Inc. Selected Pro Forma Financial Information and Non-GAAP Measures Pro Forma Operating EBITDA 1 by Segment 2 Three Months Ended Nine Months Ended In millions Sep 30, 2017 Sep 30, 2016 Sep 30, 2017 Sep 30, 2016 Agriculture $ (239) $ (172) $ 2,387 $ 2,222 Performance Materials & Coatings , Industrial Intermediates & Infrastructure ,605 1,183 Packaging & Specialty Plastics 1,147 1,386 3,424 3,856 Electronics & Imaging , Nutrition & Biosciences Transportation & Advanced Polymers Safety & Construction Corporate (223) (185) (624) (600) Total $ 3,221 $ 3,022 $ 12,228 $ 10,929 Pro Forma Significant Items by Segment (Pretax) 2 Three Months Ended Nine Months Ended In millions Sep 30, 2017 Sep 30, 2016 Sep 30, 2017 Sep 30, 2016 Agriculture $ (83) $ (14) $ (552) $ (49) Performance Materials & Coatings (140) 3 1,347 Industrial Intermediates & Infrastructure (1,312) Packaging & Specialty Plastics (10) Electronics & Imaging (50) (46) (53) 436 Nutrition & Biosciences (104) (158) 52 (159) Transportation & Advanced Polymers (68) (28) (72) 272 Safety & Construction (34) 1 (299) Corporate (649) (231) (1,253) (238) Total $ (789) $ (616) $ (1,838) $ 287 Pro Forma Equity in Earnings (Losses) of Nonconsolidated Affiliates 3 by Segment 2 Three Months Ended Nine Months Ended In millions Sep 30, 2017 Sep 30, 2016 Sep 30, 2017 Sep 30, 2016 Agriculture $ (12) $ (3) $ (9) $ (3) Performance Materials & Coatings Industrial Intermediates & Infrastructure 41 (7) 101 (49) Packaging & Specialty Plastics Electronics & Imaging Nutrition & Biosciences Transportation & Advanced Polymers Safety & Construction Corporate 8 (4) (15) (25) Total $ 161 $ 86 $ 442 $ 233 Reconciliation of "Pro forma income from continuing operations, net of tax" to "Pro forma Operating EBITDA" 2 Three Months Ended Nine Months Ended In millions Sep 30, 2017 Sep 30, 2016 Sep 30, 2017 Sep 30, 2016 Pro forma income from continuing operations, net of tax $ 259 $ 599 $ 4,071 $ 5,758 + Provision for income taxes on continuing operations , Pro forma income from continuing operations before income taxes $ 651 $ 700 $ 5,184 $ 6,369 + Depreciation and amortization 1,389 1,366 4,095 3,851 - Interest income Interest expense and amortization of debt discount Foreign exchange gains (losses), net 4 (123) (113) (378) (314) Pro forma EBITDA $ 2,432 $ 2,406 $ 10,390 $ 11,216 - Adjusted significant items 5 (789) (616) (1,838) 287 Pro forma Operating EBITDA $ 3,221 $ 3,022 $ 12,228 $ 10, The Company uses pro forma Operating EBITDA as its measure of profit/loss for segment reporting. The Company defines pro forma Operating EBITDA as earnings (i.e., pro forma Income from continuing operations before income taxes") before interest, depreciation, amortization and foreign exchange gains (losses), excluding the impact of significant items. 2. Pro forma information reflects the results of Dow and DuPont as if the Merger had occurred on January 1, Does not exclude the impact of significant items. 4. Included in "Sundry income (expense) - net." 5. Adjusted significant items, excluding the impact of one-time transaction costs directly attributable to the Merger and reflected in the pro forma adjustments.

18 DowDuPont Inc. Selected Pro Forma Financial Information and Non-GAAP Measures Reconciliation of Pro Forma Non-GAAP Measures In millions, except per share amounts Pretax Impact 1 Net Income 2 EPS - Diluted 3 Three Months Ended Sep 30, Nine Months Ended Sep 30, Three Months Ended Sep 30, Nine Months Ended Sep 30, Three Months Ended Sep 30, Nine Months Ended Sep 30, Significant Items Impacting Results Reported pro forma results $ 651 $ 700 $ 5,184 $ 6,369 $ 232 $ 494 $ 3,959 $ 5,428 $ 0.10 $ 0.22 $ 1.68 $ Significant items: Impact of Dow Corning ownership restructure 4 (212) 2,106 (144) 2,350 (0.06) 1.05 Litigation related charges, awards and adjustments 5 (332) (1,235) (215) (778) (0.08) (0.35) Inventory step-up amortization 6 (367) (367) (298) (298) (0.13) (0.13) Asset impairments and other charges 7 (158) (158) (111) (111) (0.05) (0.05) Integration and separation costs 8 (459) (160) (997) (253) (315) (125) (677) (190) (0.14) (0.05) (0.29) (0.08) Restructuring and asset related charges - net 9 (180) (17) (480) (461) (125) (14) (319) (314) (0.05) (0.01) (0.13) (0.14) Gain on sale of business/entity Transaction costs and productivity actions 11 (10) (69) (58) (140) (6) (62) (37) (122) (0.03) (0.02) (0.06) Customer claims adjustment/recovery Income tax items 13 (267) (196) (57) (0.11) (0.09) (0.02) Total significant items $ (789) $ (616) $ (1,838) $ 287 $ (876) $ (456) $ (1,516) $ 1,032 $ (0.37) $ (0.20) $ (0.64) $ DuPont amortization of intangibles (268) (267) (819) (814) (183) (180) (558) (550) (0.08) (0.08) (0.24) (0.25) Pro forma adjusted results (Non-GAAP) $ 1,708 $ 1,583 $ 7,841 $ 6,896 $ 1,291 $ 1,130 $ 6,033 $ 4,946 $ 0.55 $ 0.50 $ 2.56 $ Pro forma "Income from continuing operations before income taxes." 2. Pro forma "Net income available for DowDuPont Inc. common stockholders." The income tax effect on significant items is calculated based upon the enacted tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-gaap adjustment. 3. Pro forma "Earnings per common share from continuing operations - diluted." 4. The three months ended September 30, 2016, includes a pretax loss of $212 million for the fair value step-up in inventories, included in "Cost of sales." In addition to the previously mentioned item, the nine months ended September 30, 2016, includes the following items: - Non-taxable gain of $2,445 million related to the Dow Corning ownership restructure, included in "Sundry income (expense) - net." - Pretax loss of $105 million for the fair value step-up in inventories of Dow Corning, included in "Cost of sales." - Pretax loss of $22 million related to the early redemption of debt incurred by Dow Corning, included in "Equity in earnings of nonconsolidated affiliates." 5. The nine months ended September 30, 2017, includes a pretax loss of $469 million related to an arbitration matter with Bayer CropScience and a pretax gain of $137 million related to a patent infringement matter with Nova Chemicals Corporation, both included in "Sundry income (expense) - net." The nine months ended September 30, 2016, includes a pretax loss of $1,235 million related to Dow's settlement of the urethane matters class action lawsuit and the opt-out cases litigation, included in "Sundry income (expense) - net." 6. Pretax loss of $367 million for the fair value step-up in DuPont's inventories as a result of the Merger, included in "Cost of sales" ($360 million) and the amortization of a basis difference related to the fair value step-up in inventories, included in "Equity in earnings of nonconsolidated affiliates" ($7 million). 7. Pretax loss of $158 million related to the write-down of DuPont indefinite lived intangible assets related to the realignment of brand marketing strategies and a determination to phase out the use of certain acquired trade names. The loss was recorded in "Restructuring and asset related charges - net." 8. Integration and separation costs related to the Merger and the ownership restructure of Dow Corning, recorded in "Integration and separation costs." 9. Restructuring charges for Dow and DuPont were recorded in "Restructuring and asset related charges - net." The three months ended September 30, 2017, includes a pretax charge of $180 million related to the DowDuPont Cost Synergy Program, including $169 million of severance and $11 million of asset impairments. In addition to the previously mentioned items, the nine months ended September 30, 2017, includes the following items: - Pretax gain of $3 million related to adjustments to Dow's 2016 restructuring program. - Pretax gain of $9 million related to adjustments to Dow's 2015 restructuring program. - Pretax loss of $312 million, consisting of severance ($33 million) and asset-related charges ($279 million), primarily associated with actions to improve DuPont plant productivity. The three months ended September 30, 2016, includes a charge of $17 million related to the identification of additional asset related charges under the 2016 DuPont Global Cost Savings and Restructuring Program ("2016 DuPont Plan"). In addition to the previously mentioned item, the nine months ended September 30, 2016, includes the following items: - Restructuring plan incorporating actions related to the ownership restructure of Dow Corning resulting in pretax charges of $449 million. - Pretax loss of $5 million related to adjustments to Dow's 2015 restructuring program. - Net pretax benefit of $85 million related to a reduction in severance and related benefit costs, partially offset by additional asset related charges, all under the 2016 DuPont Plan. - Pretax loss of $75 million related to the decision to not re-start the insecticide manufacturing facility at the DuPont site in La Porte, Texas. 10. The three months ended September 30, 2017, includes a pretax gain of $227 million related to the sale of Dow's global EAA copolymers and ionomers business, included in "Sundry income (expense) - net." In addition to the previously mentioned item, the nine months ended September 30, 2017, includes: - Pretax gain of $162 million associated with the sale of DuPont's global food safety diagnostics business, included in "Sundry income (expense) - net." - Pretax gain of $7 million related to post-closing adjustments on the split-off of Dow's chlorine value chain, included in "Sundry income (expense) - net." The nine months ended September 30, 2016, includes the following items: - Pretax gain of $369 million recorded in "Sundry income (expense) - net" associated with the sale of the DuPont (Shenzhen) Manufacturing Limited entity. - Pretax gain of $6 million related to post-closing adjustments on the split-off of Dow's chlorine value chain, included in "Sundry income (expense) - net."

19 DowDuPont Inc. Selected Pro Forma Financial Information and Non-GAAP Measures 11. Includes implementation costs associated with Dow's restructuring programs and other productivity actions, recorded in: - "Cost of sales" ($8 million and $27 million in the three months ended September 30, 2017 and 2016, respectively; and $49 million and $84 million in the nine months ended September 30, 2017 and 2016, respectively). - "Selling, general and administrative expenses" ($2 million and $9 million in the three months ended September 30, 2017 and 2016, respectively; and $9 million and $23 million in the nine months ended September 30, 2017 and 2016, respectively). - "Sundry income (expense) - net" ($33 million in the three and nine months ended September 30, 2016). 12. Pretax benefit of $53 million, recorded in "Cost of sales," related to a reduction in customer claims accrual ($23 million) and insurance recoveries for recovery of costs for customer claims ($30 million) related to the use of DuPont's Imprelis herbicide. 13. Income tax items were recorded in "Provision for income taxes." The three months ended September 30, 2017, includes a tax charge of $267 million related to changes in tax attributes resulting from the Merger, including a reduction in a deferred tax asset in Germany and the recognition of deferred tax gains in the United States. In addition to this item, the nine months ended September 30, 2017, includes: - Tax benefit of $100 million related to a reduction in DuPont's unrecognized tax benefits, and reversal of associated interest, due to the closure of various tax statutes of limitations. - Tax charge of $29 million related to the elimination of a tax benefit resulting from DuPont's second quarter 2017 principal U.S. pension plan contribution. The nine months ended September 30, 2016, includes a tax charge of $57 million for an adjustment of an uncertain tax position associated with a historical change in the legal ownership structure of a Dow nonconsolidated affiliate. Pro Forma Common Shares Outstanding Three Months Ended Nine Months Ended Shares in millions Sep 30, 2017 Sep 30, 2016 Sep 30, 2017 Sep 30, 2016 Dow common shares outstanding - basic , , ,108.8 DuPont common shares outstanding - basic , ,113.2 DowDuPont common shares outstanding - basic Total DowDuPont common shares outstanding - basic 2, , , ,222.0 Dilutive impact of Dow equity-based awards Dilutive impact of DuPont equity-based awards Dilutive impact of DowDuPont equity-based awards Total DowDuPont common shares outstanding - diluted 2, , , , Reflects share amounts as reported by Dow in its Quarterly Reports on Form 10-Q and Annual Report on Form 10-K for the periods presented. The share amounts in the three- and nine-month periods ended September 30, 2017, reflect a weighted averaging effect of Dow shares outstanding prior to August 31, The three- and nine-month periods ended September 30, 2016, excludes 96.8 million shares because the effect of an assumed conversion of Dow preferred stock into Dow common stock for these periods would have been antidilutive. 2. DuPont common shares outstanding - basic for all periods presented reflects DuPont's common stock issued and outstanding at August 31, 2017, multiplied by the Merger Agreement conversion ratio of The share amounts shown in the three- and nine-month periods ended September 30, 2017, reflect a weighted averaging effect of DuPont shares outstanding prior to August 31, DowDuPont share amounts for the three- and nine-month periods ended September 30, 2017, reflect a weighted averaging effect of DowDuPont shares outstanding after August 31, The "Dilutive impact of DuPont equity-based awards" reflects share amounts as reported by DuPont in its Quarterly Reports on Form 10-Q and Annual Report on Form 10-K for the periods presented, multiplied by the Merger Agreement conversion ratio of The share amounts shown in the three- and nine-month periods ended September 30, 2017, reflect a weighted averaging effect of DuPont shares outstanding prior to August 31, Trademark of The Dow Chemical Company ("Dow") or E. I. du Pont de Nemours and Company ("DuPont") or affiliated companies of Dow or DuPont.

20 DowDuPont Inc. Unaudited Pro Forma Combined Statement of Income For the Three Months Ended September 30, 2017 Adjustments In millions, except per share amounts DWDP 1 Historical DuPont 2 Reclass 3 Divestitures 4 Pro Forma 5 Pro Forma Net sales $ 15,354 $ 3,182 $ 11 $ (225) $ (37) $ 18,285 Cost of sales 12,170 2, (106) 13 14,246 Other operating charges 141 (141) Research and development expenses (7) (26) Selling, general and administrative expenses (217) (41) 7 1,583 Other (loss) income, net (112) 112 Amortization of intangibles Restructuring and asset related charges - net (10) 180 Integration and separation costs (9) (105) 459 Equity in earnings of nonconsolidated affiliates (4) 161 Sundry income (expense) - net 361 (134) (1) 226 Interest expense and amortization of debt discount (20) 334 Income (loss) from continuing operations before income taxes 1,125 (353) 2 (44) (79) 651 Provision (credit) for income taxes on continuing operations 571 (124) 2 (10) (47) 392 Income (loss) from continuing operations, net of tax 554 (229) (34) (32) 259 Net income attributable to noncontrolling interests Net income (loss) attributable to DowDuPont Inc. 534 (234) (34) (34) 232 Preferred stock dividends 2 (2) Net income (loss) available for DowDuPont Inc. common stockholders $ 534 $ (236) $ $ (34) $ (32) $ 232 Per common share data: Earnings per common share from continuing operations - basic $ 0.10 Earnings per common share from continuing operations - diluted $ 0.10 Weighted-average common shares outstanding - basic 2,328.0 Weighted-average common shares outstanding - diluted 2, See the U.S. GAAP consolidated statements of income. 2. Reflects DuPont activity for the period from July 1, 2017 to August 31, Certain reclassifications were made to conform to the presentation that will be used for DowDuPont. The reclassifications are consistent with those identified and disclosed in the Current Report on Form 8-K/A filed with the SEC on October 26, Includes the following consummated or probable and identifiable divestitures agreed to with certain regulatory agencies as a condition of approval for the Merger, including: Dow s global EAA copolymers and ionomers business (divested on September 1, 2017); a portion of Dow AgroSciences corn seed business in Brazil (for the period of July 1, 2017 through August 31, 2017); and DuPont s cereal broadleaf herbicides and chewing insecticides portfolio as well as its crop protection research and development pipeline and organization (for the period of July 1, 2017 through August 31, 2017; September 2017 activity has been treated as discontinued operations). 5. Certain pro forma adjustments were made to illustrate the estimated effects of the Merger, assuming that the Merger had been consummated on January 1, The pro forma adjustments are consistent with those identified and disclosed in the Current Report on Form 8-K/A filed with the SEC on October 26, 2017.

21 DowDuPont Inc. Unaudited Pro Forma Combined Statement of Income For the Three Months Ended September 30, 2016 Adjustments In millions, except per share amounts Historical Dow 1 Historical DuPont 2 Reclass 3 Divestitures 4 Pro Forma 5 Pro Forma Net sales $ 12,483 $ 4,917 $ 27 $ (389) $ (47) $ 16,991 Cost of sales 9,841 3, (166) 34 12,940 Other operating charges 176 (176) Research and development expenses (10) (36) Selling, general and administrative expenses 864 1,016 (249) (56) 11 1,586 Other (loss) income, net (16) 16 Amortization of intangibles Restructuring and asset related charges - net Integration and separation costs 249 (89) 160 Equity in earnings of nonconsolidated affiliates (6) 86 Sundry income (expense) - net (4) (32) (1) (37) Interest income 26 (26) Interest expense and amortization of debt discount (30) 283 Income (loss) from continuing operations before income taxes 1,089 (56) 7 (132) (208) 700 Provision (credit) for income taxes on continuing operations 271 (69) 7 (30) (78) 101 Income from continuing operations, net of tax (102) (130) 599 Net income attributable to noncontrolling interests Net income attributable to DowDuPont Inc (102) (132) 579 Preferred stock dividends 85 2 (2) 85 Net income available for DowDuPont Inc. common stockholders $ 719 $ 7 $ $ (102) $ (130) $ 494 Per common share data: Earnings per common share from continuing operations - basic $ 0.22 Earnings per common share from continuing operations - diluted $ 0.22 Weighted-average common shares outstanding - basic 2,225.6 Weighted-average common shares outstanding - diluted 2, See the U.S. GAAP consolidated statements of income. 2. See the consolidated statements of income included in DuPont's Quarterly Report on Form 10-Q for the quarter ended September 30, Certain reclassifications were made to conform to the presentation that will be used for DowDuPont. The reclassifications are consistent with those identified and disclosed in the Current Report on Form 8-K/A filed with the SEC on October 26, Includes the following consummated or probable and identifiable divestitures agreed to with certain regulatory agencies as a condition of approval for the Merger, including: Dow s global EAA copolymers and ionomers business; a portion of Dow AgroSciences corn seed business in Brazil; and DuPont s cereal broadleaf herbicides and chewing insecticides portfolio as well as its crop protection research and development pipeline and organization. 5. Certain pro forma adjustments were made to illustrate the estimated effects of the Merger, assuming that the Merger had been consummated on January 1, The pro forma adjustments are consistent with those identified and disclosed in the Current Report on Form 8-K/A filed with the SEC on October 26, 2017.

22 DowDuPont Inc. Unaudited Pro Forma Combined Statement of Income For the Nine Months Ended September 30, 2017 Adjustments In millions, except per share amounts DWDP 1 Historical DuPont 2 Reclass 3 Divestitures 4 Pro Forma 5 Pro Forma Net sales $ 42,418 $ 18,349 $ 84 $ (1,219) $ (163) $ 59,469 Cost of sales 33,130 10, (523) 65 43,676 Other operating charges 521 (521) Research and development expenses 1,343 1,159 (27) (104) 19 2,390 Selling, general and administrative expenses 2,468 3,452 (583) (143) 29 5,223 Other (loss) income, net 173 (173) Amortization of intangibles ,286 Restructuring and asset related charges - net (10) 479 Integration and separation costs (24) (183) 997 Equity in earnings of nonconsolidated affiliates (15) 442 Sundry income (expense) - net (12) 226 Interest expense and amortization of debt discount (80) 902 Income from continuing operations before income taxes 4,067 2,196 (33) (437) (609) 5,184 Provision for income taxes on continuing operations 1, (33) (88) (233) 1,113 Income from continuing operations, net of tax 2,828 1,968 (349) (376) 4,071 Net income attributable to noncontrolling interests Net income attributable to DowDuPont Inc. 2,743 1,948 (349) (383) 3,959 Preferred stock dividends 7 (7) Net income available for DowDuPont Inc. common stockholders $ 2,743 $ 1,941 $ $ (349) $ (376) $ 3,959 Per common share data: Earnings per common share from continuing operations - basic $ 1.70 Earnings per common share from continuing operations - diluted $ 1.68 Weighted-average common shares outstanding - basic 2,322.9 Weighted-average common shares outstanding - diluted 2, See the U.S. GAAP consolidated statements of income. 2. Reflects DuPont activity for the period from January 1, 2017 to August 31, 2017, prior to the Merger. 3. Certain reclassifications were made to conform to the presentation that will be used for DowDuPont. The reclassifications are consistent with those identified and disclosed in the Current Report on Form 8-K/A filed with the SEC on October 26, Includes the following consummated or probable and identifiable divestitures agreed to with certain regulatory agencies as a condition of approval for the Merger, including: Dow s global EAA copolymers and ionomers business (divested on September 1, 2017); a portion of Dow AgroSciences corn seed business in Brazil (for the period of January 1, 2017 through August 31, 2017); and DuPont s cereal broadleaf herbicides and chewing insecticides portfolio as well as its crop protection research and development pipeline and organization (for the period of January 1, 2017 through August 31, 2017; September 2017 activity has been treated as discontinued operations). 5. Certain pro forma adjustments were made to illustrate the estimated effects of the Merger, assuming that the Merger had been consummated on January 1, The pro forma adjustments are consistent with those identified and disclosed in the Current Report on Form 8-K/A filed with the SEC on October 26, 2017.

23 DowDuPont Inc. Unaudited Pro Forma Combined Statement of Income For the Nine Months Ended September 30, 2016 Adjustments In millions, except per share amounts Historical Dow 1 Historical DuPont 2 Reclass 3 Divestitures 4 Pro Forma 5 Pro Forma Net sales $ 35,138 $ 19,383 $ 108 $ (1,305) $ (164) $ 53,160 Cost of sales 27,067 11, (557) 62 38,308 Other operating charges 504 (504) Research and development expenses 1,159 1,260 (30) (111) 21 2,299 Selling, general and administrative expenses 2,393 3,355 (478) (150) 33 5,153 Other (loss) income, net 407 (407) Amortization of intangibles ,201 Restructuring and asset related charges - net Integration and separation costs 450 (197) 253 Equity in earnings of nonconsolidated affiliates (18) 233 Sundry income (expense) - net 1, (7) 1,621 Interest income 64 (64) Interest expense and amortization of debt discount (90) 817 Income from continuing operations before income taxes 4,611 2, (497) (677) 6,369 Provision for income taxes on continuing operations (103) (240) 611 Income from continuing operations, net of tax 4,320 2,269 (394) (437) 5,758 Net income attributable to noncontrolling interests Net income attributable to DowDuPont Inc. 4,266 2,255 (394) (444) 5,683 Preferred stock dividends (7) 255 Net income available for DowDuPont Inc. common stockholders $ 4,011 $ 2,248 $ $ (394) $ (437) $ 5,428 Per common share data: Earnings per common share from continuing operations - basic $ 2.43 Earnings per common share from continuing operations - diluted $ 2.41 Weighted-average common shares outstanding - basic 2,222.0 Weighted-average common shares outstanding - diluted 2, See the U.S. GAAP consolidated statements of income. 2. See the consolidated statements of income included in DuPont's Quarterly Report on Form 10-Q for the quarter ended September 30, Certain reclassifications were made to conform to the presentation that will be used for DowDuPont. The reclassifications are consistent with those identified and disclosed in the Current Report on Form 8-K/A filed with the SEC on October 26, Includes the following consummated or probable and identifiable divestitures agreed to with certain regulatory agencies as a condition of approval for the Merger, including: Dow s global EAA copolymers and ionomers business; a portion of Dow AgroSciences corn seed business in Brazil; and DuPont s cereal broadleaf herbicides and chewing insecticides portfolio as well as its crop protection research and development pipeline and organization. 5. Certain pro forma adjustments were made to illustrate the estimated effects of the Merger, assuming that the Merger had been consummated on January 1, The pro forma adjustments are consistent with those identified and disclosed in the Current Report on Form 8-K/A filed with the SEC on October 26, 2017.

24 DowDuPont 3Q17 Earnings Conference Call November 2, 2017

25 Safe Harbor Statement Regulation G This presentation includes information that does not conform to U.S. GAAP and are considered non-gaap measures. These measures include the Company's pro forma consolidated results and pro forma earnings per share on an adjusted basis, which excludes the after-tax impact of pro forma significant items and the after-tax impact of pro forma amortization expense associated with DuPont's intangible assets. Management uses these measures internally for planning, forecasting and evaluating the performance of the Company's segments, including allocating resources. DowDuPont's management believes that these non-gaap measures best reflect the ongoing performance of the Company during the periods presented and provide more relevant and meaningful information to investors as they provide insight with respect to ongoing operating results of the Company and a more useful comparison of year-over-year results. These non-gaap measures supplement the Company's U.S. GAAP disclosures and should not be viewed as an alternative to U.S. GAAP measures of performance. Furthermore, such non-gaap measures may not be consistent with similar measures provided or used by other companies. Reconciliations of non-gaap measures to GAAP are provided in the financial schedules attached to the earnings news release and the Investor Relations section of the Company s website. DowDuPont does not provide forward-looking GAAP financial measures or a reconciliation of forward-looking non-gaap financial measures to the most comparable GAAP financial measures on a forward- looking basis because the Company is unable to predict with reasonable certainty the ultimate outcome of pending litigation, unusual gains and losses, foreign currency exchange gains or losses, potential future asset impairments and purchase accounting fair value adjustments, as well as discrete taxable events, without unreasonable effort. These items are uncertain, depend on various factors, and could have a material impact on GAAP results for the guidance period. Cautionary Statement about Forward-Looking Statements This communication contains forward-looking statements within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In this context, forward-looking statements often address expected future business and financial performance and financial condition, and often contain words such as expect, anticipate, intend, plan, believe, seek, see, will, would, target, similar expressions, and variations or negatives of these words. On December 11, 2015, The Dow Chemical Company ( Dow ) and E. I. du Pont de Nemours and Company ( DuPont ) announced entry into an Agreement and Plan of Merger, as amended on March 31, 2017, (the Merger Agreement ) under which the companies would combine in an all-stock merger of equals transaction (the Merger Transaction ). Effective August 31, 2017, the Merger Transaction was completed and each of Dow and DuPont became subsidiaries of DowDuPont Inc. ( DowDuPont ). For more information, please see each of DowDuPont s, Dow s and DuPont s latest annual, quarterly and current reports on Forms 10-K, 10-Q and 8-K, as the case may be, and the joint proxy statement/prospectus included in the registration statement on Form S-4 filed by DowDuPont with the SEC on March 1, 2016 (File No ), as last amended on June 7, 2016, and declared effective by the SEC on June 9, 2016 (the Registration Statement ) in connection with the Merger Transaction. Forward-looking statements by their nature address matters that are, to different degrees, uncertain, including the intended separation of DowDuPont s agriculture, materials science and specialty products businesses in one or more tax efficient transactions on anticipated terms (the Intended Business Separations ). Forward-looking statements are not guarantees of future performance and are based on certain assumptions and expectations of future events which may not be realized. Forward-looking statements also involve risks and uncertainties, many of which are beyond the company s control. Some of the important factors that could cause DowDuPont s, Dow s or DuPont s actual results to differ materially from those projected in any such forward-looking statements include, but are not limited to: (i) successful integration of the respective agriculture, materials science and specialty products businesses of Dow and DuPont, including anticipated tax treatment, unforeseen liabilities, future capital expenditures, revenues, expenses, earnings, productivity actions, economic performance, indebtedness, financial condition, losses, future prospects, business and management strategies for the management, expansion and growth of the combined operations; (ii) impact of the divestitures required as a condition to consummation of the Merger Transaction as well as other conditional commitments; (iii) achievement of the anticipated synergies by DowDuPont s agriculture, materials science and specialty products businesses; (iv) risks associated with the Intended Business Separations, including those that may result from the comprehensive portfolio review undertaken by the DowDuPont board, changes and timing, including a number of conditions which could delay, prevent or otherwise adversely affect the proposed transactions, including possible issues or delays in obtaining required regulatory approvals or clearances related to the Intended Business Separations, disruptions in the financial markets or other potential barriers; (v) the risk that disruptions from the Intended Business Separations will harm DowDuPont s business (either directly or as conducted by and through Dow or DuPont), including current plans and operations; (vi) the ability to retain and hire key personnel; (vii) potential adverse reactions or changes to business relationships resulting from the completion of the merger or the Intended Business Separations; (viii) uncertainty as to the long-term value of DowDuPont common stock; (ix) continued availability of capital and financing and rating agency actions; (x) legislative, regulatory and economic developments; (xi) potential business uncertainty, including changes to existing business relationships, during the pendency of the Intended Business Separations that could affect the company s financial performance and (xii) unpredictability and severity of catastrophic events, including, but not limited to, acts of terrorism or outbreak of war or hostilities, as well as management s response to any of the aforementioned factors DowDuPont. All rights reserved.

26 Safe Harbor Statement, continued Forward-Looking Statements, continued These risks, as well as other risks associated with the merger and the Intended Business Separations, are more fully discussed in (1) the Registration Statement and (2) the current, quarterly and annual reports filed with the SEC by DowDuPont and to the extent incorporated by reference into the Registration Statement, by Dow and DuPont. While the list of factors presented here is, and the list of factors presented in the Registration Statement are, considered representative, no such list should be considered to be a complete statement of all potential risks and uncertainties. Unlisted factors may present significant additional obstacles to the realization of forward-looking statements. Consequences of material differences in results as compared with those anticipated in the forward-looking statements could include, among other things, business disruption, operational problems, financial loss, legal liability to third parties and similar risks, any of which could have a material adverse effect on DowDuPont s, Dow s or DuPont s consolidated financial condition, results of operations, credit rating or liquidity. None of DowDuPont, Dow or DuPont assumes any obligation to publicly provide revisions or updates to any forward-looking statements whether as a result of new information, future developments or otherwise, should circumstances change, except as otherwise required by securities and other applicable laws. The Dow Diamond, DuPont Oval logo, DuPont and all products, unless otherwise noted, denoted with, or are trademarks or registered trademarks of The Dow Chemical Company, E. I. du Pont de Nemours and Company or their affiliates. Supplemental unaudited pro forma information for DowDuPont is presented to illustrate the estimated effects of the Merger, assuming that the Merger had been consummated on January 1, For the third quarter of 2017, activity prior to August 31, 2017 (the Merger Date ) was prepared on a pro forma basis and activity after the Merger Date was prepared on a combined U.S. GAAP basis. The unaudited pro forma information was prepared in accordance with Article 11 of Regulation S-X. Pro forma adjustments have been made for (1) the preliminary purchase accounting impact, (2) accounting policy alignment, (3) eliminate the effect of events that are directly attributable to the Merger Agreement (e.g., one-time transaction costs), (4) eliminate the impact of transactions between Dow and DuPont, and (5) eliminate the effect of consummated or probable and identifiable divestitures agreed to with certain regulatory agencies as a condition of approval for the Merger. Events that are not expected to have a continuing impact on the combined results (e.g., inventory step-up costs) are excluded. The unaudited pro forma information does not reflect restructuring or integration activities or other costs following the Merger that may be incurred to achieve cost or growth synergies of DowDuPont. The unaudited pro forma financial information provides shareholders with summary financial information and historical data that is on a basis consistent with how DowDuPont reports current financial information DowDuPont. All rights reserved.

27 Highlights DowDuPont. All rights reserved. Delivered solid 3Q17 pro forma results Sales increased 8% Volume growth of 4% Operating EBITDA up 7% Adjusted EPS increased 10% Closed the merger on August 31st Realigned the portfolio Shifted >$8B in sales, ~$2.4B in EBITDA to Specialty Products Aligned businesses along end-markets to increase competitiveness, accelerate growth Progressed two of the three remedy transactions Divestiture of Dow s ethylene acrylic acid copolymer assets (closed Sept. 1) Sale of certain DuPont crop protection assets to FMC, acquisition of most of FMC health and nutrition business (Nov. 1) Divestiture of select portion of Dow AgroSciences' corn seed business in Brazil on track to close in 4Q17

28 Strategic Drivers DowDuPont. All rights reserved. Closed transaction on Aug. 31 New reporting structure complete Pro formas delivered on Oct. 26, incorporating business realignments Re-mapping stand-and-spin timing, evaluating multiple scenarios and risk mitigation plans Stand and Spin Advancing playbook to deliver $1B in growth synergies Early examples: Ag pipeline to deliver 10 new seed products and 11 new CP products over next 5 years Combination of Dow Pharma & Food, DuPont Health & Nutrition and acquired FMC business creates one of the broadest offerings to serve industry High performance packaging solutions from integration of DuPont s ethylene copolymers portfolio Growth Synergies Remain committed to total $3B of cost synergies New division targets: Agriculture: $1.0B (no change) Materials Science: $1.2B Specialty Products: $0.8B 70% run rate by end of Year 1; 100% run rate by end of Year 2 Expect $500MM run rate by end of 4Q17 Broader cost synergy program and actions announced today Cost Synergies

29 3Q 2017 Financial Highlights Financial Performance Snapshot 3Q16 3Q17 B/(W) Pro Forma Net Sales ($MM) 16,991 18,285 +1,294 Pro Forma Operating EBITDA ($MM) 3,022 3, Pro Forma Adjusted EPS ($/share) $0.50 $0.55 +$ DowDuPont. All rights reserved. 3Q 2017 Pro Forma Adjusted EPS Variance Highlights Volume growth from consumer-led demand in key end-markets Pricing gains and currency tailwinds more than offset higher feedstock costs Higher equity earnings led by Kuwait JVs Lower pension/opeb costs Lost production and repair costs from impact of hurricanes Challenging Ag market conditions, particularly in Brazil Continued start-up spending on USGC growth projects $0.30 $ Q 1 6 V o l u m e g r o w t h M a r g i n g r o w t h f r o m p r i c e g a i n s & c u r r e n c y E q u i t y E a r n i n g s P e n s i o n / O P E B N e t I n t e r e s t e x p e n s e S t a r t - u p e x p e n s e s W e a k n e s s i n A g m a r k e t s H u r r i c a n e i m p a c t 3 Q 1 7 $0.50 $0.55

30 Agriculture: 3Q 2017 Pro Forma Highlights Pro Forma 3Q16 3Q17 Net Sales ($MM) 1,998 1,911 Op. EBITDA ($MM) (172) (239) Op. EBITDA Margin (8.6)% (12.5)% YoY Sales change: Vol (5)%, Local Price (4)% Currency +2%, Port./Other +3% Agriculture Innovation FY17 Pro Forma Outlook Crop Protection sales declined 6 percent due to high inventory levels, particularly in Brazil, pressuring both volume and price; Crop Protection volumes increased in North America Seed sales declined 11 percent excluding portfolio benefits; volume was pressured by a delayed start to the summer season in Brazil and an expected reduction in corn area Operating EBITDA¹ loss increased by $67MM due to lower price and volume, partially offset by lower product costs and pension/opeb benefit Continued penetration of new products, including ArylexTM herbicide, Leptra corn hybrids, Vessarya fungicide and IsoclastTM insecticide Robust pipeline poised to launch 10 new seed products and 11 new crop protection products over the next 5 years Sales expected to increase low-single-digits percent due to new product introductions resulting in price and volume gains Operating EBITDA expected to increase percent, driven by seed price gains, volume growth and new product launches DowDuPont. All rights reserved. 1Results for Agriculture for the third quarter of 2017 includes $13MM of EBITDA from a select portion of Dow AgroSciences corn seed remedy in Brazil for the month of September, in accordance with US GAAP. The results of this business prior to the Merger were excluded from the pro forma results, in accordance with SEC regulations. 1 Canola-LL, SSX Pro, Sunflower Clearfield Plus, RSS, ProPound, Plenish, Intacta, Leptra 2 Pyraxalt, Q8U80 Nematicide, Viovan, Aminocyclopyrachlor, XDE-659

31 Materials Science: 3Q 2017 Pro Forma Highlights Performance Materials & Coatings Industrial Intermediates & Infrastructure Packaging & Specialty Plastics Pro Forma 3Q16 3Q17 Net Sales ($MM) 2,046 2,219 Op. EBITDA ($MM) Op. EBITDA Margin 16.9% 21.9% Pro Forma 3Q16 3Q17 Net Sales ($MM) 2,770 3,226 Op. EBITDA ($MM) Op. EBITDA Margin 14.5% 21.0% Pro Forma 3Q16 3Q17 Net Sales ($MM) 5,070 5,490 Op. EBITDA ($MM) 1,386 1,147 Op. EBITDA Margin 27.3% 20.9% YoY Sales change: Vol +6%, Local Price +1% Currency +1%, Port./Other YoY Sales change: Vol +1%, Local Price +6% Currency +1%, Port./Other YoY Sales change: Vol +3%, Local Price +12% Currency +1%, Port./Other Consumer Solutions delivered sales growth in all businesses, led by volume gains in most geographies and price/volume management in silicone intermediate products Coatings & Perf. Monomers achieved higher sales as price increases in all regions more than offset a modest decline in volume due to actions to shed lower margin business Polyurethanes reported strong demand and price increases in downstream, higher- margin systems applications and increased MDI sales Industrial Solutions delivered sales gains in consumer-driven market segments of electronics processing and food and pharmaceutical applications Consumer-led demand drove sales growth in Asia Pacific and EMEA, enabled by ramp up in Sadara volumes; Americas volume impacted by hurricane-related disruptions Operating EBITDA declined as sales growth was more than offset by higher feedstock costs, hurricane impact, commissioning & start-up costs on USGC projects; marketing of additional Sadara volumes slightly impacted unit margins DowDuPont. All rights reserved.

32 Specialty Products: 3Q 2017 Pro Forma Highlights Electronics & Imaging Pro Forma 3Q16 3Q17 Net Sales ($MM) 1,138 1,198 Op. EBITDA ($MM) Op. EBITDA Margin 30.0% 31.9% Nutrition & Biosciences Transportation & Advanced Polymers Safety & Construction Broad-based volume growth across key end-markets, led by double-digit gains in semiconductor, consumer electronics, industrial, PV and display end-markets Operating EBITDA improved on volume growth, mix enrichment and lower pension/opeb costs Pro Forma 3Q16 3Q17 Net Sales ($MM) 1,469 1,473 Op. EBITDA ($MM) Op. EBITDA Margin 21.9% 21.4% Pro Forma 3Q16 3Q17 Net Sales ($MM) 1,187 1,299 Op. EBITDA ($MM) Op. EBITDA Margin 25.5% 25.0% Pro Forma 3Q16 3Q17 Net Sales ($MM) 1,238 1,310 Op. EBITDA ($MM) Op. EBITDA Margin 22.8% 26.8% YoY Sales change: Vol +6%, Local Price Currency, Port./Other YoY Sales change: Vol +13%, Local Price (2)% Currency, Port./Other (6)% YoY Sales change: Vol, Local Price Currency +1%, Port./Other (1)% YoY Sales change: Vol +5%, Local Price +3% Currency +1%, Port./Other Sales rose 9% on volume and local price gains Operating EBITDA increased 7% on volume and pricing gains and lower pension/opeb costs, partly offset by higher raw material costs Sales increased 6% on volume gains with increases in every region Operating EBITDA grew 24% due to volume growth, one-time gains, lower pension/opeb costs and better plant performance, despite higher raw materials Sales gains in microbial control solutions, probiotics and biomaterials more than offset declines in protein solutions, systems and texturants, and a negative impact from portfolio Operating EBITDA declined as sales gains in microbial and probiotics was more than offset by declines in protein solutions, systems and texturants DowDuPont. All rights reserved.

33 DowDuPont. All rights reserved. 4Q17 Modeling Guidance 4 Q 1 7 Corporate Segment Operating EBITDA ($200) ($230)MM Operational Tax Rate(excl. EGL, DuPont Amort. & Sig. Items) 24-26% D&A (includes the DuPont Amortization expense below) $1,380 $1,410MM (includes step-up D&A) DuPont Non-operating pension /OPEB2 (included in Op. EBITDA) ~$90 $110MM credit in 4Q17 DuPont Amortization expense (this is added back while calculating Adj. EPS) ~$270MM pre-tax Taxed at ~32% Net Interest Expense (net of Interest Income, which is reported in Sundry Income/Expense line) $ MM Net Income attributable to non-controlling Interests (reduced from net income) ~$30MM Share Count ~2,350MM Segment Outlook 4Q17 vs. 4Q16 Net Sales Op. EBITDA (incl. Equity Earnings) Agriculture Up ~10% ~$225MM Performance Materials & Coatings Up high-single-digits percent Up mid-teens percent Industrial Intermediates & Infrastructure Up high-teens percent Up 10-11% Packaging & Specialty Plastics Up ~10% Up low-single-digits percent Electronics & Imaging Down mid-single-digits percent Up low-single-digits percent Nutrition & Biosciences Up high-single-digits percent Up 10-11% Transportation & Advanced Polymers Up mid-single-digits percent Up mid-teens percent Safety & Construction Up mid-single-digits percent Up low-twenties percent Net Sales: $ $19.5B >7% vs. 4Q161 Op. EBITDA: 11-13% vs. 4Q161 1 All 4Q16 numbers are on a pro forma basis 2 The 4Q17 estimate for non-operating pension/opeb costs does not include any potential settlements or curtailments that could occur during the remainder of the year Note: Operating EBITDA estimates exclude approximately $1B related to a restructuring charge, which will be treated as a significant item Refer to slide 14 in Appendix for additional commentary on segment outlook

34 Outlook DowDuPont. All rights reserved. Robust demand conditions remain in consumer-driven end-markets, such as packaging, consumer electronics and transportation Ag fundamentals remain soft Full-year DowDuPont Ag results expected to increase YoY on self-help actions and innovation-led growth Packaging fundamentals remain healthy globally Demand outlook enhanced by improving global GDP growth prospects Sustainable urbanization continues to drive demand in the developing world; tighter environmental regulations could drive further upside Recent U.S. supply interruptions highlight tight supply/demand fundamentals Measured pace of capacity adds reduces duration and severity of supply/demand imbalance Market Outlook Global economic expansion on continued strength in U.S. and with notable improvements in Europe Consumer-driven strength an increasingly common theme globally Select headwinds remain, including geopolitical uncertainties and elevated emerging market debt levels Macro Outlook

35 Disciplined Focus on Financial, Strategic and Operational Results DowDuPont. All rights reserved. Deliver operating and financial plan Continued focus on volume and earnings growth Ongoing productivity and manufacturing excellence Achieve synergy targets Finalize detailed plans to achieve cost synergies & mitigate dis-synergies Achieve 70% run rate in 12 months and 100% run rate in 24 months Advance growth synergies playbook Stand and spin the intended companies Complete carve-out activities based on realignments Separate each intended company as soon as possible Remain committed to our original timeline; assessing options to accelerate 1 2 3

36

37 DowDuPont. All rights reserved. 4Q17 Segment Expectations 1 4Q16 on a pro forma basis 2 Hemlock Semiconductor Segments Key Sales and Operating EBITDA Outlook Drivers (4Q17 vs. 4Q161) Packaging & Specialty Plastics Sales growth on pricing gains, higher Sadara PE volumes and start-up of U.S. Gulf Coast growth projects. Op. EBITDA up modestly as higher prices and ramp-up of the new TX-9 and ELITE units through the quarter are mostly offset by higher feedstock costs, start-up costs (~$50MM in 4Q17), spending and volume impact of higher turnaround activity as well as a residual hurricane impact into 4Q17 (~$40MM). Industrial Intermediates & Infrastructure Sales and Op. EBITDA growth on pricing momentum and volume gains supported by tight supply-demand fundamentals. 4Q17 results impacted by lower equity earnings (down ~$40-60MM) driven by major turnaround in Equate JV. Isocyanates markets remain tight but supply improves as industry recovers from turnarounds and outages. Polyol margins under pressure from higher feedstock costs. Perf. Materials & Coatings Sales up on pricing gains. Op. EBITDA expected to grow on improved volume/mix and pricing, which more than offset headwinds from higher raw material costs. 4Q17 HSC2 pre-tax equity earnings expected to be $100-$120MM. Safety & Construction Expect continued demand from oil & gas and broader industrial markets. Raw materials costs projected to be higher year- on-year. Benefit from expected lower pension/opeb costs. Transportation & Advanced Polymers Modest price increases announced to mitigate pressure from higher raw material costs. Volumes expected to remain positive, with industry auto builds expected to be up slightly vs. last year. Tailwind from expected lower pension/opeb costs. Nutrition & Biosciences Sales up on continued growth in microbial control solutions, probiotics, biomaterials and bioactives, partially offset by continued declines in protein solutions. Op. EBITDA growth on mix enrichment and lower pension/opeb costs, partially offset by the absence of a prior year $27MM gain on asset sale. Portfolio benefit in Nov and Dec from acquisition of FMC s Health & Nutrition business. Electronics & Imaging Sales expected to be down vs. the year-ago period as continued growth in semiconductors, consumer electronics and displays will be more than offset by the negative impact of portfolio (sale of stake in a non-core JV in 2Q17) and declines in photovoltaics volumes due to Hurricane Maria-driven supply disruption in Puerto Rico. Op. EBITDA expected to be up on mix enrichment, productivity gains and lower pension/opeb costs. Agriculture Ag segment sales growth driven by increased fungicide volumes and the continued penetration of Leptra corn hybrids. Benefits from lower pension/opeb costs and the inclusion of the Brazil corn seed remedy (until the expected close of transaction in 4Q17) will be partially offset by continued price pressure within the crop protection business. Refer in conjunction with Slide 10

38 3Q16 3Q17-60% -50% -40% -30% -20% -10% 0% M a r g i n $ i n M i l l i o n s DowDuPont. All rights reserved. 3Q Pro Forma Operating EBITDA 3Q17 Pro Forma Sales Ag markets continue to be challenging driven by lower expected corn planted area, elevated crop protection inventory levels, and weak farm economics. 3Q operating EBITDA¹ loss increased by $67MM as lower sales were partially offset by lower product costs and benefits from currency and portfolio FY17 Outlook: Sales expected to increase low-single-digits percent due to new product introductions resulting in price and volume gains. Op. EBITDA expected to increase percent driven by top line price gains and volume growth Crop Protection 3Q sales down as high industry inventory levels, driven by Brazil, and competitive markets resulted in volume and price declines FY17 Outlook: Driving full year new product volume gains with Vessarya fungicide, ArylexTM herbicide, Isoclast herbicide, and novel Seed Treatment solutions Seed 3Q sales down as portfolio and currency benefits were more than offset by lower volume and pricing Quarterly volume declines driven by a delayed start to the summer season in Brazil and South Africa and expected lower planted corn area also in Brazil. Quarterly price declines driven by higher replant in the U.S. due to wet conditions during planting FY17 Outlook: Driving full year volume and seed price gains from increased penetration of Leptra corn hybrids, Enlist cotton, and A- series soybeans Seed Crop Protection North America Asia Pacific Europe Latin America Pro Forma Sales down 4% vs 3Q16 Vol -5%, Local Price -4%, Currency 2%, Port./Other 3% Agriculture 1. Results for Agriculture for the third quarter of 2017 includes $13MM of EBITDA from a select portion of Dow AgroSciences corn seed remedy in Brazil for the month of September, in accordance with US GAAP. The results of this business prior to the Merger were excluded from the pro forma results, in accordance with SEC regulations.

39 Performance Materials & Coatings DowDuPont. All rights reserved. 3Q16 3Q17 0.0% 5.0% 10.0% 15.0% 20.0% 25.0% M a r g i n $ i n M i l l i o n s 3Q Pro Forma Operating EBITDA 3Q17 Pro Forma Sales 3,928 Coatings & Performance Monomers Consumer Solutions Coatings & Performance Monomers Consumer Solutions North America Asia Pacific EMEA Latin America Pro Forma Sales 8% vs 3Q16 Vol 1%, Local Price 6%, Currency 1% Higher prices in all geographic areas Modest decline in volume related to hurricane-related lost sales and actions to shed lower margin business Op. EBITDA growth as price gains more than offset modest volume decline and higher raw material costs Robust sales growth in all businesses led by volume growth in silicones and price/volume management in upstream silicone intermediate products Op. EBITDA growth on continued silicones cost synergy capture, increased pricing and solid consumer demand

40 Ind. Intermediates & Infrastructure DowDuPont. All rights reserved. 3Q16 3Q17 0.0% 5.0% 10.0% 15.0% 20.0% 25.0% M a r g i n $ i n M i l l i o n s 3Q Pro Forma Operating EBITDA 3Q17 Pro Forma Sales 3,928 Constr. Chem. Energy Sol. Ind. Sol. PU & CAV North America Asia Pacific EMEA Latin America Pro Forma Sales up 16% vs 3Q16 Vol 3%, Local Price 12%, Currency 1% Construction Chemicals Demand growth in acrylics-based and methyl cellulosics products Modest decline in pro forma op. EBITDA due to raw materials cost increases that were partially offset by volume and price increases Polyurethanes & CAV Robust demand for PU systems; tight MDI and caustic fundamentals continued Op. EBITDA rose on price gains and broad-based volume growth Energy Solutions Sales declined due to decreased project activity in oil & gas Pro forma op. EBITDA improved due to scale down of solar operations that was partially offset by decreased project activity in oil & gas Industrial Solutions Strong sales gains led by glycol ethers, ethylene glycol and oxo alcohols in consumer-led market segments of electronics processing, crop defense and food & pharma Pro forma op. EBITDA improved on pricing momentum, higher equity earnings and volume growth

41 Sales Higher sales driven by volume growth and price gains Volume grew 6 percent on consumer-led demand across packaging, health & hygiene and footwear applications Double-digit volume gains in health & hygiene end-markets in the Americas and strong demand in food and specialty packaging applications, particularly in Asia Pacific Hurricane-related disruptions impacted polyethylene, ethylene co-polymers and wire and cable production Pro forma op. EBITDA of $1.1B reflects pricing gains and higher equity earnings, more than offset by increased feedstock costs, hurricane-related repair costs and lost production, and USGC commissioning and startup costs Other Highlights New world-scale ethylene unit and ELITE enhanced PE units both came online on U.S. Gulf Coast; will continue to ramp to full rates in 4Q New LDPE capacity reached mechanical completion; on track for startup in 1Q18 Packaging & Specialty Plastics DowDuPont. All rights reserved. 3Q16 3Q % 20.0% 30.0% 40.0% ,000 1,050 1,100 1,150 1,200 1,250 1,300 1,350 1,400 M a r g i n $ i n M i l l i o n s 3Q Pro Forma Operating EBITDA 3Q17 Pro Forma Sales 3,928 Hydrocarbons & Energy Packaging & Spec Plastics EBITDA North America Latin America EMEA Asia Pacific Pro Forma Sales up 8% vs 3Q16 Vol +6%, Local Price +1%, Currency +1%, Port./Other 1,386 1,147

42 Electronics & Imaging DowDuPont. All rights reserved. 3Q16 3Q % 20.0% 30.0% 40.0% M a r g i n $ i n M i l l i o n s 3Q Pro Forma Operating EBITDA 3Q17 Pro Forma Sales Sales 13 percent volume growth across key end-markets and almost all geographic areas, primarily Asia Pacific Double-digit gains in semiconductor, consumer electronics, industrial, photovoltaics and display end-markets Growth in semiconductor as strong demand for memory and logic segments drove component manufacturing across mobile devices, automotive and consumer electronics Local price declined 2 percent on pressure in Solamet paste and advanced printing applications 6 percent negative impact from portfolio changes (Display Films and Authentication) Operating EBITDA Op. EBITDA increased 12 percent on broad-based volume growth, mix enrichment and lower pension/opeb costs more than offset lower local price and a negative impact from portfolio Op. EBITDA margins expanded by about 190 basis points North America Asia Pacific Europe Latin America Pro Forma Sales 5% vs 3Q16 Vol 13%, Local Price (2)%, Currency, Port./Other (6)%

43 Nutrition & Biosciences DowDuPont. All rights reserved. 3Q16 3Q % 20.0% 30.0% 40.0% M a r g i n $ i n M i l l i o n s 3Q Pro Forma Operating EBITDA 3Q17 Pro Forma Sales Pro Forma Sales vs 3Q16 Vol, Local Price, Currency 1%, Port./Other (1)% Nutrition & Health Industrial Biosciences North America Asia Pacific Europe Latin America Industrial Biosciences Pro forma net sales grew on improved demand for microbials, bioactives and biomaterials Microbial demand improved across all geographies, primarily in North America on growth in energy markets Biomaterials growth led by local price gains and demand for Sorona in apparel, primarily in Asia Pacific Operating EBITDA Op. EBITDA declined 2 percent as double-digit sales gains in probiotics, microbial control and biomaterials was more than offset by declines in protein solutions, systems and texturants Nutrition & Health Pro forma net sales declined as continued strength in probiotics was more than offset by declines in protein solutions and systems & texturants and a negative impact from portfolio (sale of Diagnostics) Double-digit volume growth in probiotics, led by China Soft market conditions in global packaged foods, customer destocking in the U.S. and business-specific actions to exit low margin markets continue to impact protein solutions and systems & texturants

44 Transportation & Adv. Polymers DowDuPont. All rights reserved. 3Q16 3Q % 20.0% 30.0% 40.0% M a r g i n $ i n M i l l i o n s 3Q Pro Forma Operating EBITDA 3Q17 Pro Forma Sales 3,928 Sales Pro forma sales increased 9 percent to $1.3 billion due to volume and local price gains Strong demand from the automotive market, particularly in Asia Pacific, Latin America and EMEA; growth outpaced auto industry overall, led by polymers and parts, including Kalrez and Vespel as well as structural adhesives and MolyKote lubricants Price gains in nearly all regions Pro forma op. EBITDA increased 7 percent to $325 million on volume and pricing gains and lower pension/opeb costs, partly offset by higher raw material costs Operating EBITDA North America Asia Pacific Europe Latin America Pro Forma Sales 9% vs. 3Q16 Vol 5%, Local Price 3%, Currency 1%, Port./Other